SUNJIN BEAUTY SCIENCE CO. LTD.

As of June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. carries a market capitalization of 79.39B, placing it among publicly traded companies globally. Its enterprise value stands at 143.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

SUNJIN BEAUTY SCIENCE CO. LTD.'s next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. has 12.01M shares outstanding.

As of June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. trades at a trailing price-to-earnings ratio of 15.90. The price-to-sales ratio is 0.96, and the price-to-book ratio stands at 0.92.

As of June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. trades at an EV/EBITDA multiple of 12.27 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.73 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 41.05 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 143.15B versus a market cap of 79.39B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. maintains a current ratio of 1.29, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 79.38, indicating elevated leverage, while an interest coverage ratio of 10.29 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. posted a return on equity (ROE) of 5.90, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 2.79, measuring how efficiently the asset base is converted into earnings. The company generates approximately 383.51M in revenue per employee across its workforce of 216.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.87 indicates how many times SUNJIN BEAUTY SCIENCE CO. LTD. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. recorded an income tax benefit of -158.59M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 6.05B, leaving 4.99B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, SUNJIN BEAUTY SCIENCE CO. LTD.'s stock has declined approximately 38.09% over the past 52 weeks. The 50-day moving average sits at 7,213.80, while the 200-day moving average is 8,494.60.

Over the twelve months ended June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. generated 82.93B in revenue and converted that into 4.99B in net income, yielding earnings per share of 516.56. EBITDA reached 11.66B, while operating income came in at 3.49B.

As of June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. holds 12.92B in cash and equivalents against 72.10B in total debt, resulting in a net debt position of 59.04B. Total book value stands at 86.23B, with working capital of 13.48B providing operational flexibility.

SUNJIN BEAUTY SCIENCE CO. LTD. produced 4.76B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -11.28B in capital expenditures, free cash flow totaled -6.52B - equivalent to -542.56 per share.

Over the twelve months ended June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. posted a gross margin of 39.78, reflecting its pricing power and cost economics. The operating margin of 4.20 and net profit margin of 6.02 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. paid dividends of 106.74 per share. The dividend payout ratio of 17.28 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -8.21: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 1.16, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to SUNJIN BEAUTY SCIENCE CO. LTD. shareholders.

SUNJIN BEAUTY SCIENCE CO. LTD.'s most recent stock split took place on March 10, 2022 with a 1:2 split ratio.

As of June 30, 2026, SUNJIN BEAUTY SCIENCE CO. LTD. has an Altman Z-Score of 1.69, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.